• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于前药的多功能纳米医学具有物理和生理肿瘤穿透性,可增强癌症化疗免疫治疗。

Prodrug-Based Versatile Nanomedicine with Simultaneous Physical and Physiological Tumor Penetration for Enhanced Cancer Chemo-Immunotherapy.

机构信息

State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau 999078, China.

Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China.

出版信息

Nano Lett. 2021 May 12;21(9):3721-3730. doi: 10.1021/acs.nanolett.0c04772. Epub 2021 Apr 23.

DOI:10.1021/acs.nanolett.0c04772
PMID:33891423
Abstract

Chemo-immunotherapy combination effect remains to be a great challenge due to the poor tumor penetration of therapeutic agents that resulted from condensed extracellular matrix (ECM), T cell-related immune escape, and thus the potential recurrence. Herein, a helix self-assembly camptothecin (CPT) prodrug with simultaneous physical and physiological tumor penetration was constructed to realize effective chemo-immunotherapy. Specifically, CPT was modified with arginine to self-assemble into nanofibers to physically improve tumor penetration. Two plasmids, shPD-L1 and Spam1 for expressing small hairpin RNA PD-L1 and hyaluronidase, respectively, were loaded to down-regulate tumor surface PD-L1 expression for converting anergic state of T cells into the tumor-reactive T cells and produce hyaluronidase to physiologically degrade ECM for further enhanced tumor penetration. Moreover, the degraded ECM could also increase immune cells' infiltration into tumor sites, which may exert a synergistic antitumor immunity combined with immune checkpoint inhibition. Such a nanomedicine could cause significant inhibition of primary, distant tumors, and effective prevention of tumor recurrence.

摘要

由于治疗药物由于细胞外基质(ECM)的凝聚、T 细胞相关免疫逃逸而导致的肿瘤穿透性差,化学免疫疗法的联合效果仍然是一个巨大的挑战,因此存在潜在的复发风险。在此,构建了一种具有同时物理和生理肿瘤穿透能力的螺旋自组装喜树碱(CPT)前药,以实现有效的化学免疫治疗。具体而言,将 CPT 用精氨酸修饰以自组装成纳米纤维,从而物理地提高肿瘤穿透性。两种质粒,shPD-L1 和 Spam1,分别用于表达小发夹 RNA PD-L1 和透明质酸酶,用于下调肿瘤表面 PD-L1 表达,将 T 细胞的无反应状态转化为对肿瘤有反应的 T 细胞,并产生透明质酸酶来生理降解 ECM,以进一步增强肿瘤穿透性。此外,降解的 ECM 还可以增加免疫细胞浸润到肿瘤部位,这可能与免疫检查点抑制相结合发挥协同抗肿瘤免疫作用。这种纳米药物可以显著抑制原发性、远处肿瘤,并有效预防肿瘤复发。

相似文献

1
Prodrug-Based Versatile Nanomedicine with Simultaneous Physical and Physiological Tumor Penetration for Enhanced Cancer Chemo-Immunotherapy.基于前药的多功能纳米医学具有物理和生理肿瘤穿透性,可增强癌症化疗免疫治疗。
Nano Lett. 2021 May 12;21(9):3721-3730. doi: 10.1021/acs.nanolett.0c04772. Epub 2021 Apr 23.
2
Efficient PD-L1 gene silence promoted by hyaluronidase for cancer immunotherapy.透明质酸酶促进的高效 PD-L1 基因沉默用于癌症免疫治疗。
J Control Release. 2019 Jan 10;293:104-112. doi: 10.1016/j.jconrel.2018.11.022. Epub 2018 Nov 23.
3
A Self-amplifying ROS-sensitive prodrug-based nanodecoy for circumventing immune resistance in chemotherapy-sensitized immunotherapy.一种基于自扩增 ROS 敏感前药的纳米诱骗物,用于规避化疗增敏免疫治疗中的免疫抵抗。
Acta Biomater. 2022 Sep 1;149:307-320. doi: 10.1016/j.actbio.2022.06.035. Epub 2022 Jun 25.
4
A versatile strategy to create an active tumor-targeted chemo-photothermal therapy nanoplatform: A case of an IR-780 derivative co-assembled with camptothecin prodrug.一种多功能策略构建主动肿瘤靶向化疗-光热治疗纳米平台:以 IR-780 衍生物与喜树碱前药共组装为例。
Acta Biomater. 2019 Jan 15;84:356-366. doi: 10.1016/j.actbio.2018.11.049. Epub 2018 Nov 29.
5
Tumor microenvironment-activated therapeutic peptide-conjugated prodrug nanoparticles for enhanced tumor penetration and local T cell activation in the tumor microenvironment.肿瘤微环境激活的治疗性肽偶联前药纳米颗粒,用于增强肿瘤微环境中的肿瘤穿透和局部 T 细胞激活。
Acta Biomater. 2021 Jan 1;119:337-348. doi: 10.1016/j.actbio.2020.11.008. Epub 2020 Nov 6.
6
Tumor-dilated polymersome nanofactories for enhanced enzyme prodrug chemo-immunotherapy.肿瘤扩张聚合物囊泡纳米工厂用于增强酶前药化学免疫治疗。
J Control Release. 2021 Nov 10;339:418-429. doi: 10.1016/j.jconrel.2021.10.015. Epub 2021 Oct 16.
7
Prodrug-Based Versatile Nanomedicine for Enhancing Cancer Immunotherapy by Increasing Immunogenic Cell Death.基于前药的多功能纳米医学通过增加免疫原性细胞死亡增强癌症免疫治疗。
Small. 2020 May;16(19):e2000214. doi: 10.1002/smll.202000214. Epub 2020 Apr 20.
8
Cobalt(III) prodrug-based nanomedicine for inducing immunogenic cell death and enhancing chemo-immunotherapy.基于钴(III)前药的纳米医学诱导免疫原性细胞死亡和增强化疗免疫治疗。
J Control Release. 2024 Sep;373:493-506. doi: 10.1016/j.jconrel.2024.07.042. Epub 2024 Jul 25.
9
Prodrug nanoparticles potentiate tumor chemo-immunometabolic therapy by disturbing oxidative stress.前药纳米颗粒通过扰乱氧化应激增强肿瘤化疗免疫代谢治疗。
J Control Release. 2022 Dec;352:909-919. doi: 10.1016/j.jconrel.2022.11.011. Epub 2022 Nov 14.
10
Trident Molecule with Nanobrush-Nanoparticle-Nanofiber Transition Property Spatially Suppresses Tumor Metastasis.具有纳米刷-纳米颗粒-纳米纤维转变特性的三叉分子空间抑制肿瘤转移。
J Am Chem Soc. 2022 Jul 6;144(26):11897-11910. doi: 10.1021/jacs.2c05743. Epub 2022 Jun 22.

引用本文的文献

1
Nano drug delivery systems for advanced immune checkpoint blockade therapy.用于先进免疫检查点阻断疗法的纳米药物递送系统
Theranostics. 2025 Apr 13;15(11):5440-5480. doi: 10.7150/thno.112475. eCollection 2025.
2
Interim PET after 4 cycles predicts outcome in histomolecularly confirmed primary mediastinal B-cell lymphoma.4个周期后的中期正电子发射断层扫描(PET)可预测经组织分子学确诊的原发性纵隔B细胞淋巴瘤的预后。
Blood Adv. 2025 May 13;9(9):2232-2246. doi: 10.1182/bloodadvances.2024015577.
3
Polymeric Polylactic Acid-Glycolic Acid-Based Nanoparticles Deliver Nintedanib Across the Blood-Brain Barrier to Inhibit Glioblastoma Growth.
基于聚乳酸-乙醇酸的聚合物纳米颗粒可携带尼达尼布穿过血脑屏障,抑制胶质母细胞瘤生长。
Int J Mol Sci. 2025 Jan 7;26(2):443. doi: 10.3390/ijms26020443.
4
Enhancing drug penetration in solid tumors via nanomedicine: Evaluation models, strategies and perspectives.通过纳米药物增强实体瘤中的药物渗透:评估模型、策略与展望。
Bioact Mater. 2023 Oct 26;32:445-472. doi: 10.1016/j.bioactmat.2023.10.017. eCollection 2024 Feb.
5
Tumor-overexpressed enzyme responsive amphiphiles small molecular self-assembly nano-prodrug for the chemo-phototherapy against non-small-cell lung cancer.肿瘤过表达酶响应性两亲性小分子自组装纳米前药用于非小细胞肺癌的化学光疗
Mater Today Bio. 2023 Jul 4;21:100722. doi: 10.1016/j.mtbio.2023.100722. eCollection 2023 Aug.
6
Active Ingredients from Chinese Medicine for Combination Cancer Therapy.中药活性成分用于联合癌症治疗。
Int J Biol Sci. 2023 Jul 9;19(11):3499-3525. doi: 10.7150/ijbs.77720. eCollection 2023.
7
Advances in nanomaterial-based targeted drug delivery systems.基于纳米材料的靶向药物递送系统的进展。
Front Bioeng Biotechnol. 2023 Apr 13;11:1177151. doi: 10.3389/fbioe.2023.1177151. eCollection 2023.
8
Linear-like polypeptide-based micelle with pH-sensitive detachable PEG to deliver dimeric camptothecin for cancer therapy.具有pH敏感可分离聚乙二醇的线性样多肽基胶束用于递送二聚喜树碱进行癌症治疗。
Asian J Pharm Sci. 2023 Jan;18(1):100773. doi: 10.1016/j.ajps.2022.100773. Epub 2023 Jan 3.
9
Non-apoptotic cell death-based cancer therapy: Molecular mechanism, pharmacological modulators, and nanomedicine.基于非凋亡性细胞死亡的癌症治疗:分子机制、药理学调节剂与纳米医学
Acta Pharm Sin B. 2022 Sep;12(9):3567-3593. doi: 10.1016/j.apsb.2022.03.020. Epub 2022 Apr 1.
10
Nanomaterials: A powerful tool for tumor immunotherapy.纳米材料:肿瘤免疫治疗的有力工具。
Front Immunol. 2022 Aug 22;13:979469. doi: 10.3389/fimmu.2022.979469. eCollection 2022.